Cargando…
Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis
BACKGROUND: Metformin is effective for the treatment of polycystic ovary syndrome, but conflicting results regarding its effect on adipocytokine levels (adiponectin, resistin, visfatin, and leptin) in patients with polycystic ovary syndrome receiving metformin treatment have been reported. To provid...
Autores principales: | Kong, Wen, Niu, Xun, Zeng, Tianshu, Lu, Meixia, Chen, Lulu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608563/ https://www.ncbi.nlm.nih.gov/pubmed/26473366 http://dx.doi.org/10.1371/journal.pone.0140565 |
Ejemplares similares
-
Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023) -
Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis
por: Zeng, Xian-Ling, et al.
Publicado: (2016) -
Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis
por: Wu, Zeng-Hong, et al.
Publicado: (2019) -
Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017) -
Impact of metformin on C-reactive protein levels in women with polycystic ovary syndrome: a meta-analysis
por: Chen, Yong, et al.
Publicado: (2017)